Pioneer Fil-Med Files Draft Papers for Rs 500-Crore Initial Public Offering

Pioneer Fil-Med Files Preliminary IPO Papers with SEBI

Summary

Pioneer Fil-Med, a New Delhi-based railway and metro equipment manufacturing company, has filed preliminary papers with the Securities and Exchange Board of India (SEBI) to raise up to Rs 500 crore via an initial public offering (IPO).

IPO Details

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

The IPO will comprise a fresh issue and an offer-for-sale of shares, each worth Rs 250 crore. The promoters, Pioneer Facor IT Infradevelopers and Aztech India, plan to sell shares worth Rs 125 crore each via the offer-for-sale.

Pre-IPO Placement

The company may consider raising up to Rs 50 crore before filing the Red Herring Prospectus for the IPO launch. This pre-IPO placement will be part of the fresh issue component.

Company Overview

Read also: Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

Pioneer Fil-Med commenced operations in 2001 with the manufacture of filters for railway and automotive applications. The company has diversified its product portfolio to include traction motors, alternators, brake discs, gangways, stators, and rotors for locomotives, platform screen doors for metros, and wind generators. With three manufacturing facilities in Haryana, Pioneer Fil-Med is an approved supplier of advanced traction products to Indian Railways.

IPO Utilization

The company plans to spend Rs 102.2 crore from the fresh issue for establishing a gear box manufacturing facility and Rs 79.5 crore for a wind generator components manufacturing facility at Salarpur, Rajasthan. The remaining funds will be utilized for general corporate purposes, while the offer-for-sale funds will be received by selling shareholders.

Financial Performance

Pioneer Fil-Med has recorded a healthy financial performance in recent years. The company's profit in the year ended March 2025 grew 53.2% to Rs 40.4 crore from Rs 26.4 crore in the previous year. Revenue during the same period surged 40.1% to Rs 326.4 crore from Rs 233 crore. Profit in the April-September period of the current financial year was Rs 25.4 crore on revenue of Rs 156 crore.

IPO Managers

Nuvama Wealth Management and Equirus Capital have been appointed as the book running lead managers for the Pioneer Fil-Med IPO.